--:--:--

Mangalam Drugs And Organics Limited

Web: mangalamdrugs.com NSE: MANGALAM BSE: 532637 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

31 0(0%)

Volume

29k as on 19, Jun

Open

114

High

114

Low

112

Close

31

VWAP

30

52 Week High

73

52 Week Low

23

Viand Research Rating
Quality Score

17/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

48

No. of Shares

1.58

P/E

18

P/B

1.19

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

6.62

ROCE

-

Profit Growth

-

Listing Date

23-May-05

Rank/Sector Rank

#3831/#225

Promoter Holding

35.65%

FII Holding

0.11%

DII Holding

-

Price Chart
Price Performance
1 Week7%
1 Month6%
3 Months6%
6 Months25%
1 Year57%
YTD4%
Moving Average
5 Day SMA30
10 Day SMA29
20 Day SMA30
30 Day SMA28
50 Day SMA28
61 Day SMA34
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 332303132
Resistance 231303131
Resistance 131303031
Pivot Point30303030
Support 130303030
Support 229303029
Support 329302929
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 35.65%(0.01) 35.65%(-14.71) 35.64%(0.01) 50.30%(0.01) 50.30%(0.01) 50.30%(0.01) 50.30%(0.01) 50.30%(0.01) 50.31%(0.01) 50.31%(0.01) 50.31%(0.01) 50.31%(0.01) 50.31%(0.01) 50.31%(-0.11) 50.31%(0.01) 50.41%(-0.11) 50.42%(0.01) 50.53%(0.01) 50.53%(0.01) 50.53%
FIIs(-0.21) 0.11%(0.21) 0.32%(0.01) 0.13%(-0.41) 0.11%(0.11) 0.53%(0.41) 0.47%(0.01) 0.11%(-0.11) 0.11%(-0.11) 0.21%(0.21) 0.26%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.11) 0.10%(0.01) 0.00%(0.01) 0.00%
DIIs(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.01%(0.01) 0.01%(0.01) 0.01%(0.01) 0.01%
Public64.24%64.03%64.22%49.57%49.16%49.23%49.58%49.58%49.47%49.42%49.59%49.59%49.58%49.59%49.58%49.49%49.47%49.36%49.46%49.46%
No. of Shareholders24,46525,14021,22719,88119,72819,69719,67919,50819,31219,17318,61017,97817,89017,94317,91118,48318,98820,08420,66821,071
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
Sales57.1267.2958.3849.5457.2172.7888.7179.9476.53102.2497.34
Sales Growth % (YoY)-0.2%-7.5%-34.2%-38%-25.2%-28.8%-8.9%----
Sales Growth % (QoQ)-15.1%15.3%17.8%-13.4%-21.4%-18%11%4.5%-25.1%5%-
Expenses56.2172.9159.9252.3861.8362.8879.9471.2468.3490.5590.36
Operating Profit0.91-5.62-1.54-2.84-4.629.98.778.78.1911.696.98
OPM %1.59-8.35-2.64-5.73-8.0813.69.8910.8810.711.437.17
Other Income0.110.090.220.030.140.470.140.140.020.050
Interest3.683.084.055.034.044.033.493.673.753.953.31
Depreciation4.094.664.464.634.484.74.053.973.883.863.63
Profit before tax-6.75-13.27-9.83-12.47-131.641.371.20.583.930.04
Tax %13.191.130-41.066.1595.735.84-124.17-362.0710.18-1150
Net Profit -7.64-13.42-9.84-7.35-13.80.061.292.692.683.530.5
Net Profit Growth % (QoQ)43.1%-36.4%-33.9%46.7%-23100%-95.3%-52%0.4%-24.1%606%-
Net Profit Growth % (YoY)44.6%-22466.7%-862.8%-373.2%-614.9%-98.3%158%----
TTM Net Profit-38.25-44.41-30.93-19.8-9.766.7210.199.46.714.030
EPS in Rs-4.83-8.48-6.22-4.64-8.720.040.821.71.692.230.32
Profit and Loss
Mar 2026Mar 2025Mar 2024
Sales232318369
Sales Growth %-27.1%-13.7%-
Expenses247282351
Operating Profit-153617
OPM %-6114.7
Other Income100
Interest161514
Depreciation181715
Profit before tax-495-11
Tax %-9-41-18
Net Profit -447-9
Net Profit Growth %-728.6%177.8%-
EPS in Rs-28.054.25-5.73
Dividend Payout %000
Cash Flows
Mar 2026Mar 2025Mar 2024
Cash from Operating Activity4434
Cash from Investing Activity-12-19-12
Cash from Financing Activity6-225
Net Cash Flow-21-3
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024
Equity Capital1616161616
Reserves87112133132120
Borrowings105959683107
Other Liabilities1069412113391
Total Liabilities315317366364334
Fixed Assets159159163161148
CWIP04308
Investments00000
Other Assets156155201203178
Total Assets315317366364334
Delivery

Delivery Data: MANGALAM

#Date
26
49%
38
Value (Cr)Q/T
147		Del
62		Del
0
121-Oct30
0
54750
219-Oct31
0
76570
316-Oct31
0
79780
415-Oct32
0
59860
514-Oct32
0
108890
613-Oct32
0
92790
712-Oct32
0
59730
89-Oct31
1
131340
98-Oct31
0
82780
107-Oct33
0
106830
116-Oct32
0
88600
125-Oct29
0
127750
131-Oct29
0
70690
1430-Sep31
0
71730
1529-Sep31
0
66530
1628-Sep31
0
52580
1725-Sep32
0
47830
1824-Sep32
0
86740
1923-Sep32
0
96570
2022-Sep32
0
82630
2121-Sep33
0
145680
2218-Sep34
1
115600
2317-Sep32
0
87670
2416-Sep32
0
77730
2515-Sep34
0
112700
2611-Sep36
1
142561
2710-Sep35
1
247821
289-Sep32
0
114710
298-Sep29
0
84760
307-Sep30
0
63720
314-Sep30
0
83740
323-Sep30
0
116660
332-Sep30
0
111510
341-Sep30
0
121710
3531-Aug32
0
70710
3628-Aug32
0
111660
3727-Aug32
0
109750
3826-Aug31
0
153770
3925-Aug33
1
153550
4024-Aug30
1
243790
4121-Aug28
0
133890
4220-Aug27
0
73420
4319-Aug27
0
102660
4418-Aug28
0
165730
4517-Aug28
0
127660
4614-Aug28
0
110610
4713-Aug28
0
101700
4812-Aug27
0
135720
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct48c16L0.33
19-Oct48c79L1.61
17-Oct49c00
16-Oct49c1c2.12
15-Oct50c1c2.70
14-Oct52c71L1.40
13-Oct51c55L1.10
12-Oct50c71L1.40
09-Oct51c1c2.22
08-Oct50c3c5.92
05-Oct47c92L1.91
01-Oct48c2c3.41
29-Sep50c1c2.92
28-Sep48c2c4.69
25-Sep51c79L1.59
24-Sep50c2c3.90
22-Sep52c19L0.37
17-Sep52c4c6.36
10-Sep55c8c17.32
07-Sep47c60L1.26
04-Sep48c00
Stock Checklist
Price is above from 52 week high low average: 16%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0